Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
boston blog main
life sciences
national blog main
san francisco blog main
2
×
san francisco top stories
2
×
azacitidine
beta-thalassemia
boston
boston top stories
cancer diagnostics
dacogen
deals
decitabine
dna
epigenetics
epizyme
farydak
flagship pioneering
freenome
fulcrum therapeutics
grail
guardant health
insulated genomic domains
kaleido biosciences
liquid biopsy
lucence
mahesh karande
national top stories
new york blog main
new york top stories
omega therapeutics
panobinostat
richard young
robert gould
rudolf jaenisch
san francisco
sickle cell disease
startups
syros pharmaceuticals
What
based
2
×
developing
2
×
aims
announced
approach
area
bay
biopsy
biotech
blood
buildout
called
cancer
close
company
debuts
drugs
epigenetic
epigenetics
field
firm
flagship’s
genomic
liquid
lucence
medicine
medicines
morning
new
omega
plans
research
screening
selection
startup
step
tests
therapeutics
touting
tow
Language
unset
Current search:
biotech
×
developing
×
" san francisco blog main "
×
" san francisco top stories "
×
based
×
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
